查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575748

全球胆红素测量仪市场 - 2024-2031

Global Bilirubin Meters Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球胆红素计量仪市场规模达1.081亿美元，预计2031年将达到1.364亿美元，2024-2031年预测期间复合年增长率为10.16%。

胆红素计是一种测量患者血液中胆红素含量的装置。是诊断和治疗新生儿黄疸的重要工具。它通常使用分光光度法来测量胆红素水平，这有助于诊断和监测黄疸、肝臟疾病和溶血性疾病等疾病。

胆红素测定仪可用于便携式和实验室环境，为临床决策提供重要资料。通常用于新生儿评估黄疸，确定其严重程度以及是否需要治疗，例如光疗。它们有助于评估和分析胆红素代谢，并有助于诊断肝臟疾病，如肝炎、肝硬化和其他代谢性疾病。

市场动态：

驱动程式和限制

胆红素测定仪的技术进步

胆红素测定仪的技术进步预计将推动市场成长。增强的测量技术，例如增强的分光光度法和多波长分析，可以产生更一致的结果，从而增强对这些仪器的信任。非侵入性胆红素检测仪利用光感测器透过皮肤监测胆红素水平，预计将提高筛检的舒适度和可及性，尤其是对于婴儿。

小型化和使用者介面设计的进步带来了更便携、易于使用的设备，医疗保健专业人员只需很少的指导即可操作这些设备，从而可以广泛使用。更快的分析时间提高了临床环境中的工作流程效率，从而可以快速做出诊断和治疗决策。技术进步可以降低製造成本，使医疗机构的胆红素测定仪更便宜，并提高市场份额。因此，上述因素预计将推动市场成长。

设备成本高

医院和诊所，特别是中低收入地区的医院和诊所，可能需要帮助购买昂贵的设备。这可能会限制他们投资新技术的能力，从而阻碍新技术的采用。如果有更便宜的选择，未来的买家可能会选择它们，从而使高价产品难以竞争。这可能会导致优质产品的市场占有率下降。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 胆红素测定仪的技术进步
    • 限制
      • 设备成本高
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 报销分析
  • 专利分析
  • SWOT分析
  • DMI 意见

第 6 章：依产品类型

  • 桌上型
  • 经皮

第 7 章：按年龄组

  • 新生儿
  • 成年人
  • 其他的

第 8 章：依指示

  • 肝炎
  • 黄疸
  • 其他的

第 9 章：最终用户

  • 医院
  • 诊所
  • 诊断中心
  • 其他的

第 10 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Delta Medical International Ltd
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Mennen Medical Ltd
  • Ningbo David Medical Device Co. Ltd.
  • Micro Lab Instruments
  • Zeal Medical
  • Dragerwerk AG & Co. KGaA
  • Labtron Equipment Ltd
  • Korrida Medical Systems
  • GPC Medical Ltd
  • Braun & Co. Limited

第 13 章：附录

简介目录
Product Code: MD5378

Overview

Global Bilirubin Meters Market reached US$ 108.1 million in 2023 and is expected to reach US$ 136.4 million by 2031, growing at a CAGR of 10.16% during the forecast period 2024-2031.

The bilirubin meter is a device that measures the amount of bilirubin in a patient's blood. It is an important tool in the diagnosis and treatment of neonatal jaundice. It typically uses spectrophotometric methods to measure bilirubin levels, which aids in the diagnosis and monitoring of illnesses like jaundice, liver disease, and hemolytic disorders.

Bilirubin meters can be found in both portable and laboratory settings, giving essential data for clinical decision-making. Commonly used in neonates to assess jaundice, determining its severity and the need for treatment, such as phototherapy. They help in evaluating and analyzing bilirubin metabolism and help in diagnosing liver diseases such as hepatitis, cirrhosis, and other metabolic diseases.

Market Dynamics: Drivers & Restraints

Technological advancement in bilirubin meters

Technological advancements in bilirubin meters are expected to drive the market growth. Enhanced measuring techniques, such as enhanced spectrophotometry and multi-wavelength analysis, produce more consistent results, boosting trust in these instruments. Non-invasive bilirubin meters, that utilize light sensors to monitor bilirubin levels via the skin are expected to improve the comfort and accessibility of screening, especially for babies.

Advances in miniaturization and user interface design have led to more portable, simple-to-use devices that can be operated by healthcare professionals with minimal instruction, allowing for widespread use. Faster analysis times improve workflow efficiency in clinical environments, allowing for rapid diagnostic and treatment decisions. Technological advancements can result in lower manufacturing costs, making bilirubin meters cheaper for healthcare facilities and boosting market share. Thus, the above factors are expected to drive the market growth.

High cost of the devices

Hospitals and clinics, particularly in low- and middle-income areas, may need help with funding costly equipment. This can limit their ability to invest in new technologies, impeding their adoption. If cheaper options exist, buyers in the future may choose them, making it difficult for high-priced products to compete. This could result in a lower market share for premium products.

Segment Analysis

The global bilirubin meters market is segmented based on product type, age group, indication, end-user, and region.

Transcutaneous segment is expected to dominate the market share

The transcutaneous segment holds a significant position in the global market share and is expected to continue throughout the forecast period. These gadgets are non-invasive, accurate, cost-effective, and time-saving.

Moreover, transcutaneous devices are used to screen jaundice in newborn babies without a needle prick, and they are becoming more popular as an alternative to serum bilirubin analyzers. Transcutaneous bilirubinometers serve as a valid screening method for identifying neonates who require total serum bilirubin measurement before phototherapy.

Transcutaneous meters produce immediate results, allowing for more rapid clinical decision-making and rapid action in situations like as jaundice. Due to their efficiency and portability, these devices are gaining demand and are expected to hold a significant position in the market share.

Geographical Analysis

North America is expected to hold a significant position in the bilirubin meters market share

North America accounted for the highest revenue share. The increasing prevalence of liver diseases, the rising geriatric population, rising healthcare spending, well-established infrastructure, and technological advancements in bilirubin meters are factors expected to boost the market in the forecast period.

For instance, according to the Children's Hospital of Philadelphia in 2024, it is stated that hyperbilirubinemia is very common, affecting approximately 60 percent of term newborns and 80 percent of premature babies develop jaundice. The increasing number of hyperbilirubinemias requires continuous evaluation and analysis of the quantity of bilirubin, thus increasing the demand for the devices. Thus, the above factors are expected to hold the region's market growth.

Market Segmentation

By Product Type

  • Bench-top
  • Transcutaneous

By Age Group

  • Neonates
  • Adults
  • Others

By Indication

  • Hepatitis
  • Jaundice
  • Others

By End-User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the market include Delta Medical International Ltd, Mennen Medical Ltd, Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zeal Medical, Dragerwerk AG & Co. KGaA, Labtron Equipment Ltd, Korrida Medical Systems, GPC Medical Ltd and Braun & Co. Limited. among others.

Why Purchase the Report?

  • To visualize the global bilirubin meters market segmentation based on product type, age group, indication, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of bilirubin meters market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global bilirubin meters market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Age Group
  • 3.3. Snippet by Indication
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancement in bilirubin meters
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of the devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Bench-top*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Transcutaneous

7. By Age Group

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 7.1.2. Market Attractiveness Index, By Age Group
  • 7.2. Neonates*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Adults
  • 7.4. Others

8. By Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 8.1.2. Market Attractiveness Index, By Indication
  • 8.2. Hepatitis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Jaundice
  • 8.4. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Diagnostic Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
      • 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
      • 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
      • 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.3.1. The U.S.
      • 10.2.3.2. Canada
      • 10.2.3.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
      • 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
      • 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.4.1. Germany
      • 10.3.4.2. UK
      • 10.3.4.3. France
      • 10.3.4.4. Italy
      • 10.3.4.5. Spain
      • 10.3.4.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
      • 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
      • 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.4.1. Brazil
      • 10.4.4.2. Argentina
      • 10.4.4.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
      • 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
      • 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.4.1. China
      • 10.5.4.2. India
      • 10.5.4.3. Japan
      • 10.5.4.4. South Korea
      • 10.5.4.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
      • 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
      • 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Delta Medical International Ltd*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Mennen Medical Ltd
  • 12.3. Ningbo David Medical Device Co. Ltd.
  • 12.4. Micro Lab Instruments
  • 12.5. Zeal Medical
  • 12.6. Dragerwerk AG & Co. KGaA
  • 12.7. Labtron Equipment Ltd
  • 12.8. Korrida Medical Systems
  • 12.9. GPC Medical Ltd
  • 12.10. Braun & Co. Limited

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us